Drug
Salmon Calcitonin
Salmon Calcitonin is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph phase_4
2
50%
Ph phase_3
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 32 (50.0%)
Phase 42 (50.0%)
Trials by Status
withdrawn125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
withdrawnphase_4
Calcitonin in the Treatment of Fibromyalgia
NCT00754884
completedphase_3
Bone Microstructure in Nasal Salmon Calcitonin Treated Postmenopausal Women
NCT00372099
completedphase_3
A Study for Patients With Osteoporosis
NCT00414973
completedphase_4
Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women
NCT00239889
Clinical Trials (4)
Showing 4 of 4 trials
NCT00754884Phase 4
Calcitonin in the Treatment of Fibromyalgia
NCT00372099Phase 3
Bone Microstructure in Nasal Salmon Calcitonin Treated Postmenopausal Women
NCT00414973Phase 3
A Study for Patients With Osteoporosis
NCT00239889Phase 4
Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4